SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated scores highest on Nitro (90) and lowest on Earnings (30). Its PosiPenta is 66.73 out of 100, better than most similar companies.
Compared with similar companies in the Industrials sector in United States.
The five pillars
Details
PPrice
| P/E ratio | 11.23 |
| P/B ratio | 2.06 |
EEarnings
| Trailing EPS | ₹44.55 |
| Forward EPS | ₹51.18 |
NNitro
| Price | 500.45 |
| 52-week high | 549.08 |
| 52-week low | 263.49 |
| Fall from 52-week high | 8.9% |
TTorque
| Return on equity (ROE) | 18.91% |
| Debt-to-equity | 0.17 |
AAnchor
| Beta (price swings) | 0.55 |
| Market cap | ₹5,146 Cr |
| Insider holding | 81.53% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is SBC Medical Group Holdings Incorporated's PosiPenta score?
SBC Medical Group Holdings Incorporated's PosiPenta is 66.73 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for SBC Medical Group Holdings Incorporated?
Nitro (momentum), with a score of 90 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for SBC Medical Group Holdings Incorporated?
Earnings (growth), with a score of 30 out of 100: weaker than most similar companies.
Has SBC Medical Group Holdings Incorporated's PosiPenta changed since last week?
Yes, it fell 0.86 points, from 67.59 to 66.73.
PositoAI is for research and education only and is not investment advice.